Standout Papers

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer 2008 2026 2014 2020 1.7k
  1. Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer (2008)
    David Cunningham, Naureen Starling et al. New England Journal of Medicine
  2. EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer (2008)
    Alberto Sobrero, Joan Maurel et al. Journal of Clinical Oncology
  3. The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies (2015)
    Leisha A. Emens, Gary Middleton Cancer Immunology Research
  4. Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial (2013)
    Thomas K. Waddell, Ian Chau et al. The Lancet Oncology
  5. Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial (2013)
    Hugo Ford, Andrea Marshall et al. The Lancet Oncology

Immediate Impact

5 by Nobel laureates 4 from Science/Nature 107 standout
Sub-graph 1 of 18

Citing Papers

Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death
2024 Standout
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
2021 Standout

Works of Gary Middleton being referenced

KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer
2017
Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials
2016

Author Peers

Author Last Decade Papers Cites
Gary Middleton 5307 4105 818 1934 175 8.7k
Markus Moehler 4979 3952 1081 2657 321 8.4k
Hans Prenen 3897 2558 1536 1275 202 8.3k
Keun‐Wook Lee 3882 3178 647 1935 260 7.0k
Hidetaka Mochizuki 4452 2523 876 3131 229 8.8k
Yelena Y. Janjigian 4791 4844 1043 2284 246 8.2k
Marina Talamonti 4686 2020 1475 2548 202 8.1k
Naureen Starling 3674 2630 968 1562 166 6.1k
Kun‐Huei Yeh 3332 2247 882 1366 253 6.5k
Michele Orditura 3324 2067 996 1187 179 5.9k
Won Ki Kang 5792 5912 1836 3532 344 11.8k

All Works

Loading papers...

Rankless by CCL
2026